第 1 到 10 筆結果,共 10 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | The UCHL5 inhibitor b-AP15 overcomes cisplatin resistance via suppression of cancer stemness in urothelial carcinoma | PO-MING CHOW ; Dong, Jun-Ren; Chang, Yu-Wei; Kuo, Kuan-Lin; WEI-CHOU LIN ; SHING-HWA LIU ; KUO-HOW HUANG | Molecular Therapy Oncolytics | 6 | 5 | |
2 | 2021 | CDK7 inhibition by THZ1 suppresses cancer stemness in both chemonaïve and chemoresistant urothelial carcinoma via the hedgehog signaling pathway | PO-MING CHOW ; Chang, Yu-Wei; Kuo, Kuan-Lin; WEI-CHOU LIN ; SHING-HWA LIU ; KUO-HOW HUANG | Cancer letters | 7 | 7 | |
3 | 2020 | The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma | PO-MING CHOW ; SHING-HWA LIU ; Chang Y.-W.; Kuo K.-L.; WEI-CHOU LIN ; KUO-HOW HUANG | Cancer Letters | 16 | 18 | |
4 | 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | WEI-CHOU LIN ; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; CHIA-TUNG SHUN ; Shi C.-S.; HONG-CHIANG CHANG ; YU-CHIEH TSAI ; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG | Journal of Molecular Medicine | 1 | 1 | |
5 | 2019 | Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway | Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; WEI-CHOU LIN ; Shi C.-S.; PO-MING CHOW ; Liao S.-M.; Pan C.-I.; Hong J.-Y.; HONG-CHIANG CHANG ; KUO-HOW HUANG | International Journal of Molecular Sciences | 16 | 16 | |
6 | 2019 | Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study | Kuo K.-L.; SHING-HWA LIU ; WEI-CHOU LIN ; Hsu F.-S.; PO-MING CHOW ; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; HONG-CHIANG CHANG ; KUO-HOW HUANG | International Journal of Molecular Sciences | 18 | 18 | |
7 | 2019 | Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study | Shi C.-S.; Kuo K.-L.; Chen M.-S.; PO-MING CHOW ; Liu S.-H.; Chang Y.-W.; WEI-CHOU LIN ; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; HONG-CHIANG CHANG ; KUO-HOW HUANG | Cells | 8 | 9 | |
8 | 2019 | The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study | Kuo K.-L.; Liu S.-H.; WEI-CHOU LIN ; PO-MING CHOW ; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; HONG-CHIANG CHANG ; KUO-HOW HUANG | Cells | 16 | 18 | |
9 | 2018 | Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience | Lien C.-C.; KAO-LANG LIU ; PO-MING CHOW ; WEI-CHOU LIN ; Tai H.-C.; CHAO-YUAN HUANG ; SHUO-MENG WANG ; KUO-HOW HUANG ; YEONG-SHIAU PU | Urological Science | 3 | 4 | |
10 | 2018 | Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma | WEI-CHOU LIN ; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; CHIA-TUNG SHUN ; Shi C.-S.; HONG-CHIANG CHANG ; YU-CHIEH TSAI ; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG | Journal of Molecular Medicine | 8 | 9 |